1.36
price down icon9.93%   -0.15
after-market Handel nachbörslich: 1.43 0.07 +5.15%
loading

Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.34%
18.78
16.57 16.45 16.81 11.79
Operating Income/Loss
13.34%
-18.78
-16.57 -16.45 -16.81 -11.79
Net Income/Loss
13.28%
-17.80
-15.72 -15.54 -15.80 -10.85
Basic Average Shares
12.48%
50.87
45.23 0.5728 39.74 39.57
Diluted Average Shares
12.48%
50.87
45.23 0.5728 39.74 39.57
Basic Earnings Per Share
0.00%
-0.35
-0.35 -0.38 -0.40 -0.27
Diluted Earnings Per Share
0.00%
-0.35
-0.35 -0.38 -0.40 -0.27
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):